Literature DB >> 9890159

Inhibition and induction of human cytochrome P450 (CYP) enzymes.

O Pelkonen1, J Mäenpää, P Taavitsainen, A Rautio, H Raunio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9890159     DOI： 10.1080/004982598238886

Source DB:  PubMed          Journal:  Xenobiotica        ISSN： 0049-8254            Impact factor:   1.908


× No keyword cloud information.
  33 in total

1.  Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation.

Authors:  S Palovaara; K T Kivistö; P Tapanainen; P Manninen; P J Neuvonen; K Laine
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

2.  Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.

Authors:  Winnie Jeng; Peter G Wells
Journal:  ACS Chem Neurosci       Date:  2010-02-23       Impact factor: 4.418

3.  In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.

Authors:  Yang Song; Shanshan Li; Ying Shi; Lipei Zhao; Yu Cui; Lei Yao; Yu Zhen; Ruili Chen; Yan Cui
Journal:  Braz J Microbiol       Date:  2020-06-17       Impact factor: 2.476

4.  Identification of canine cytochrome P-450s (CYPs) metabolizing the tramadol (+)-M1 and (+)-M2 metabolites to the tramadol (+)-M5 metabolite in dog liver microsomes.

Authors:  Tania E Perez Jimenez; Katrina L Mealey; Darren Schnider; Tamara L Grubb; Stephen A Greene; Michael H Court
Journal:  J Vet Pharmacol Ther       Date:  2018-08-16       Impact factor: 1.786

5.  Topical timolol for treatment of epistaxis in hereditary haemorrhagic telangiectasia associated with bradycardia: a look at CYP2D6 metabolising variants.

Authors:  Narendranath Epperla; Murray H Brilliant; Humberto Vidaillet
Journal:  BMJ Case Rep       Date:  2014-02-11

Review 6.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Novel cyclic phosphate prodrug approach for cytochrome P450-activated drugs containing an alcohol functionality.

Authors:  Kristiina M Huttunen; Niina Mähönen; Jukka Leppänen; Jouko Vepsäläinen; Risto O Juvonen; Hannu Raunio; Hanna Kumpulainen; Tomi Järvinen; Jarkko Rautio
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

8.  Ru(ii) polypyridyl complexes as photocages for bioactive compounds containing nitriles and aromatic heterocycles.

Authors:  Ao Li; Claudia Turro; Jeremy J Kodanko
Journal:  Chem Commun (Camb)       Date:  2018-02-01       Impact factor: 6.222

9.  Quantitative drug interactions prediction system (Q-DIPS): a dynamic computer-based method to assist in the choice of clinically relevant in vivo studies.

Authors:  P Bonnabry; J Sievering; T Leemann; P Dayer
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 10.  Tobacco control for anesthesiologists.

Authors:  David O Warner
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.